These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36094871)
1. Is multifocality a risk factor in low-risk papillary thyroid cancer? Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871 [TBL] [Abstract][Full Text] [Related]
2. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer? Elbasan O; Ilgın C; Gogas Yavuz D Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491 [TBL] [Abstract][Full Text] [Related]
4. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
5. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma. Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study. Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709 [TBL] [Abstract][Full Text] [Related]
7. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis. Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769 [TBL] [Abstract][Full Text] [Related]
8. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer. Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424 [TBL] [Abstract][Full Text] [Related]
9. The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents. Sun Y; Liu Y; Li H; Tang Y; Liu W; Zhang Y; Yin D BMC Cancer; 2024 Jun; 24(1):690. PubMed ID: 38844891 [TBL] [Abstract][Full Text] [Related]
10. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression. Khan M; Syed AA; Khan AI; Hussain SR; Urooj N Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398 [TBL] [Abstract][Full Text] [Related]
11. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma. Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082 [TBL] [Abstract][Full Text] [Related]
12. Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study. Omi Y; Haniu K; Kamio H; Fujimoto M; Yoshida Y; Horiuchi K; Okamoto T World J Surg Oncol; 2022 Dec; 20(1):394. PubMed ID: 36510206 [TBL] [Abstract][Full Text] [Related]
13. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer. Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841 [TBL] [Abstract][Full Text] [Related]
14. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY. Liu YQ; Li H; Liu JR; Lin YS Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228 [No Abstract] [Full Text] [Related]
15. Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study. Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1606-1614. PubMed ID: 37222185 [TBL] [Abstract][Full Text] [Related]
16. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526 [TBL] [Abstract][Full Text] [Related]
17. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer? Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089 [TBL] [Abstract][Full Text] [Related]
18. Treatment for microcarcinoma of the thyroid--clinical experience. Küçük NO; Tari P; Tokmak E; Aras G Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients. Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159 [TBL] [Abstract][Full Text] [Related]
20. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis. Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]